Nova scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
A Discounted Cash Flow model estimates what a company could be worth by projecting its future cash flows and then discounting those back to today, using a required rate of return. It is essentially asking what future cash generated for shareholders is worth in current dollars.
For Nova, the model used is a 2 Stage Free Cash Flow to Equity approach. The latest twelve month free cash flow is US$219.21 million. Analyst inputs and Simply Wall St extrapolations project free cash flow reaching US$590.83 million in 2035, with interim projections such as US$262.90 million in 2026 and US$344.15 million in 2027. These values are discounted back to today using the model’s rate. This produces a total estimated intrinsic value of US$121.10 per share.
Compared with the recent share price of US$440.72, this DCF output implies that Nova trades at a very large premium, with an intrinsic discount figure that suggests the stock is 263.9% overvalued on this model.
Result: OVERVALUED
Our Discounted Cash Flow (DCF) analysis suggests Nova may be overvalued by 263.9%. Discover 62 high quality undervalued stocks or create your own screener to find better value opportunities.
For profitable companies, the P/E ratio is a useful way to relate what you pay for each share to the earnings that share currently generates. Investors tend to accept a higher or lower P/E depending on expectations for future earnings growth and how risky those earnings are, so what counts as a normal or fair P/E varies by company and industry.
Nova currently trades on a P/E of 54.0x. That sits above the wider Semiconductor industry average of 38.2x, but below the peer group average of 84.8x. To sharpen this further, Simply Wall St also calculates a proprietary Fair Ratio, which is the P/E you might expect for Nova given its earnings growth profile, industry, profit margins, market cap and specific risks. For Nova, this Fair Ratio is 33.2x.
The Fair Ratio can be more useful than a simple peer or industry comparison because it adjusts for company specific traits rather than assuming all semiconductor names deserve similar multiples. Setting Nova’s current P/E of 54.0x against the Fair Ratio of 33.2x suggests the shares trade at a premium to what this framework would consider reasonable.
Result: OVERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Earlier it was mentioned that there is an even better way to understand valuation. This is where Narratives come in, a simple story you create that links your view on Nova’s business to a set of revenue, earnings and margin assumptions. These flow into a forecast and then a Fair Value that you can compare with the current price to help decide whether to buy, hold or sell, all within the Narratives tool on Simply Wall St’s Community page. This tool is used by millions of investors and automatically refreshes when new news or earnings arrive. For example, one investor might lean toward a higher Fair Value closer to US$500.00 based on expectations around metrology demand, while another leans toward a more cautious Fair Value nearer US$335.00. You can see both stories quantified side by side and decide which one fits your own view of Nova.
For Nova however we will make it really easy for you with previews of two leading Nova Narratives:
Each one bakes in different assumptions about wafer fab spending, metrology intensity and how much you might be willing to pay for future earnings. Use them as starting points, then decide which set of expectations feels closer to your own view.
Fair value in this narrative: US$497.25 per share
Implied discount to that fair value at the last close of US$440.72: about 11.4% undervalued
Revenue growth assumption: 16.1% a year
Fair value in this narrative: US$335.00 per share
Implied premium to that fair value at the last close of US$440.72: about 31.6% overvalued
Revenue growth assumption: 14.7% a year
If you want to see how other investors are framing similar assumptions around growth, margins and P/E multiples, it can help to scan a wider set of companies that combine solid fundamentals with balance sheet strength instead of focusing on Nova alone, and then compare how its current pricing lines up against that group using a structured screener. solid balance sheet and fundamentals stocks screener (39 results)
Do you think there's more to the story for Nova? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English